Bevacizumab for recurrent ependymoma.

Green, R M

Bevacizumab for recurrent ependymoma. [electronic resource] - Neurology Nov 2009 - 1677-80 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1526-632X

10.1212/WNL.0b013e3181c1df34 doi


Adult
Aged
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Brain Neoplasms--drug therapy
Disease Progression
Drug Therapy, Combination
Ependymoma--drug therapy
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Retrospective Studies
Time Factors
Treatment Outcome
Young Adult